• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • About
  • Team
  • News
EyeBio

EyeBio

  • Business Development
  • Contact

Back to Team

Sam Smart

Vice President, Finance

LinkedIn

Sam joined EyeBio as Vice President of Finance. She has over 25 years of experience, with a background that includes senior managerial positions in both finance and operations at established and emerging life science companies.

Prior to joining EyeBio, Sam worked with Acacia Pharma Ltd., Nodthera Ltd., Glyconics Ltd., Iceni Glycoscience Ltd., and PBD Biotech Ltd. She also worked in Corporate Finance at PricewaterhouseCoopers, LLP. Sam is also currently Director of Operations (previously Head of Finance) at Artios Pharma Ltd.

Sam holds a B.Sc. (Hons) in Applied Microbiology from Heriot-Watt University and an M.Sc. in International Securities, Investment, and Banking from the University of Reading.

Footer

Contact Us

Please fill out the brief form below with any questions or inquiries, and a member of our team will connect with you soon.

Business Development

EyeBio is bringing disruptive innovation to the field of ophthalmology. We actively seek to expand our pipeline of promising investigational therapies, and we welcome inquiries regarding in-licensing and acquisition of assets into our portfolio.

To learn more, please contact Sarah Milsom, Chief Operating Officer of EyeBio, at s.milsom@nulleyebiotech.com.

Privacy Policy
Terms of Use
Cookie Policy
Accessibility Statement

EyeBio

LinkedIn

Copyright © 2022 EyeBio

logo
  • About
  • Team
  • News
  • Business Development
  • Contact